Floatz logo

Capecitabine

Stomach Neoplasms

SUNHO（China）BioPharmaceutical CO., Ltd.Small moleculePhase 3Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
64/ 100
Competitive Position
81/ 100

Competitive context

34 Active assets in the Stomach Neoplasms cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Seagen, a wholly owned subsidiary of Pfizer
Phase 4BBB
Eloxatin
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Jazz Pharmaceuticals
Phase 3BB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 3BB
Pembrolizumab
Merck Sharp & Dohme LLC
Phase 3BB

View all 50 →

Same molecule, other indications

Capecitabine is also rated in:

Locally Advanced Rectal CancerDormant
BBB
Indicative ·
75 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →
rectal carcinomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →